Literature DB >> 6121787

Effect of sulphasalazine on the human intestinal flora.

M P Hazenberg, M Bakker, H C Both-Patoir, J G Ruseler-van Embden, A M Schröder.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6121787     DOI: 10.1111/j.1365-2672.1982.tb04379.x

Source DB:  PubMed          Journal:  J Appl Bacteriol        ISSN: 0021-8847


× No keyword cloud information.
  7 in total

Review 1.  Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease.

Authors:  Gert De Hertogh; Jeroen Aerssens; Karen P Geboes; Karel Geboes
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

2.  High concentration and retained amidation of fecal bile acids in patients with active ulcerative colitis.

Authors:  N Tanida; Y Hikasa; M Dodo; K Sawada; A Kawaura; T Shimoyama
Journal:  Gastroenterol Jpn       Date:  1986-06

3.  Antibiotic residues and drug resistance in human intestinal flora.

Authors:  D E Corpet
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

4.  Faecal bile acid excretion in children with inflammatory bowel disease.

Authors:  J Ejderhamn; J J Rafter; B Strandvik
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

5.  Effect of antibiotics on the human intestinal flora in mice.

Authors:  M P Hazenberg; M Van de Boom; M Bakker; J P Van de Merwe
Journal:  Antonie Van Leeuwenhoek       Date:  1983-06       Impact factor: 2.271

6.  Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora.

Authors:  S Pecquet; A Andremont; C Tancrède
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

7.  Modulation of Gut Microbiome Composition and Function in Experimental Colitis Treated with Sulfasalazine.

Authors:  Haihui Zheng; Mingyi Chen; Yuan Li; Yuanyuan Wang; Lin Wei; Ziqiong Liao; Mengxia Wang; Fangli Ma; Qiongfeng Liao; Zhiyong Xie
Journal:  Front Microbiol       Date:  2017-09-07       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.